Latest liposarcoma Stories
MADRID, February 3, 2015 /PRNewswire/ -- PharmaMar announces that the U.S.
RARITAN, N.J., Feb. 3, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
Additionally, Trabectedin Expanded Access Program Now Allows Entry of Eligible Patients with Previously Treated Advanced Soft Tissue Sarcoma, Including those with Liposarcoma and Leiomyosarcoma
This groundbreaking report explains the risks and benefits of learning about sarcomas on the Internet, providing valuable insights into how medical teams and organizations can better serve patients
- Large; stout; burly.